Up a level |
Jenei, Kristina, Lythgoe, Mark P. and Vokinger, Kerstin N. (2024) Shortages of essential cancer medicines: who is responsible and what are the possible solutions? The Lancet Oncology, 25 (1). 23 - 26. ISSN 1470-2045
Vokinger, Kerstin N., Perényi, Gellért and Wouters, Olivier J. ORCID: 0000-0002-2514-476X (2023) Investments in research and development for supplemental drug indications: implications for drug price negotiations. JAMA Health Forum, 4 (9). E232798. ISSN 2689-0186
Vokinger, Kerstin N. and Naci, Huseyin (2022) Negotiating drug prices in the US - lessons from Europe. JAMA Health Forum, 3 (12). ISSN 2689-0186
Carl, David L., Laube, Yannic, Serra-Burriel, Miquel, Naci, Huseyin, Ludwig, Wolf Dieter and Vokinger, Kerstin N. (2022) Comparison of uptake and prices of biosimilars in the US, Germany, and Switzerland. JAMA network open, 5 (12). ISSN 2574-3805
Vokinger, Kerstin N., Hwang, Thomas J., Carl, David L., Laube, Yannic, Ludwig, Wolf Dieter, Naci, Huseyin and Kesselheim, Aaron S. (2022) Price changes and within-class competition of cancer drugs in the USA and Europe: a comparative analysis. The Lancet Oncology, 23 (4). 514 - 520. ISSN 1470-2045